20 results
IBS-D Pharmacotherapy

Loperamide
Rifaximin
Eluxadoline
Alosetron
Antispasmodics
Tricyclic antidepressants
SSRIs

#IBSD #IBS #Diarrhea #Irritable #Bowel #Syndrome #pharmacology #table #comparison #management #treatment
#IBS #Diarrhea ... #Irritable #Bowel ... #Syndrome #pharmacology ... #table #comparison ... #management #treatment
IBS-C Pharmacotherapy

Polyethylene glycol
Lubiprostone
Linaclotide
Plecanatide
Tegaserod
Tenapanor

#IBSC #IBS #Constipation #Irritable #Bowel #Syndrome #pharmacology #table #comparison #management #treatment
IBS-C Pharmacotherapy ... Constipation #Irritable #Bowel ... #Syndrome #pharmacology ... #table #comparison ... #management #treatment
Inflammatory Bowel Disease (IBD) - Inpatient Management Checklist
History and physical examination
 - Assess for disease severity
Inflammatory Bowel ... Disease (IBD) - ... Radiographic evaluation Medication ... #IBD #Inflammatory ... #Bowel #Disease
Guide to Treatment of Hepatitis C with Direct Acting Antivirals.

Here is a pocket guide to initial
Guide to Treatment ... guide to initial treatment ... response to the ID ... #Management #Pharmacology ... #Guide #Medications
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Penicilliosis #IDSA ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 400 mg PO BID ... candida #mucosal #IDSA ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
jirovecii pneumonia, id ... InfectiousDiseases #Infections #Pharmacology ... #Management #Treatment ... #Indications
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... • Continue treatment ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... IsosporaBelli #IDSA ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... #Encephalitis #IDSA ... #Prevention #Treatment ... #opportunistic ... #pharmacology